Just as these five studies show conflicting results for hormone therapies including tamoxifen and aromatase inhibitors, they all vary in study design and analysis.

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...

In a 6-month period, the majority of women taking AIs were more likely than those on tamoxifen to have an increase in tenosynovial changes as seen on magnetic resonance imaging, and a decrease in grip ...